Skip to main navigation
Skip to search
Skip to main content
Search by expertise, name or affiliation
Immunogenicity, reactogenicity and safety study of Pediarix, Hiberix and Prevenar 13 co-administered with two different formulations of GSK Biologicals' HRV vaccine (444563) in healthy infants 6-12 weeks of age.
Texas College of Osteopathic Medicine
Effective start/end date
Biotechnology & Drug Development, Immunology